Innoviva, Inc. (INVA)
20.66
+0.04
(+0.19%)
USD |
NASDAQ |
Sep 11, 16:00
20.67
+0.01
(+0.05%)
Pre-Market: 20:00
Innoviva Price to Book Value : 1.217 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.217 |
| September 10, 2026 | 1.214 |
| September 09, 2026 | 1.244 |
| September 08, 2026 | 1.257 |
| September 04, 2026 | 1.256 |
| September 03, 2026 | 1.258 |
| September 02, 2026 | 1.258 |
| September 01, 2026 | 1.242 |
| August 31, 2026 | 1.223 |
| August 28, 2026 | 1.235 |
| August 27, 2026 | 1.234 |
| August 26, 2026 | 1.251 |
| August 25, 2026 | 1.247 |
| August 24, 2026 | 1.239 |
| August 21, 2026 | 1.241 |
| August 20, 2026 | 1.237 |
| August 19, 2026 | 1.265 |
| August 18, 2026 | 1.252 |
| August 17, 2026 | 1.234 |
| August 14, 2026 | 1.248 |
| August 13, 2026 | 1.222 |
| August 12, 2026 | 1.226 |
| August 11, 2026 | 1.222 |
| August 10, 2026 | 1.218 |
| August 07, 2026 | 1.208 |
| Date | Value |
|---|---|
| August 06, 2026 | 1.243 |
| August 05, 2026 | 1.208 |
| August 04, 2026 | 1.229 |
| August 03, 2026 | 1.223 |
| July 31, 2026 | 1.235 |
| July 30, 2026 | 1.250 |
| July 29, 2026 | 1.275 |
| July 28, 2026 | 1.285 |
| July 27, 2026 | 1.254 |
| July 24, 2026 | 1.263 |
| July 23, 2026 | 1.249 |
| July 22, 2026 | 1.262 |
| July 21, 2026 | 1.271 |
| July 20, 2026 | 1.253 |
| July 17, 2026 | 1.279 |
| July 16, 2026 | 1.308 |
| July 15, 2026 | 1.289 |
| July 14, 2026 | 1.280 |
| July 13, 2026 | 1.308 |
| July 10, 2026 | 1.310 |
| July 09, 2026 | 1.308 |
| July 08, 2026 | 1.321 |
| July 07, 2026 | 1.310 |
| July 06, 2026 | 1.285 |
| July 02, 2026 | 1.314 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Zevra Therapeutics, Inc. | 3.274 |
| Collegium Pharmaceutical, Inc. | 2.370 |
| CorMedix, Inc. | 1.319 |
| ANI Pharmaceuticals, Inc. | 2.700 |
| Corcept Therapeutics, Inc. | 17.25 |
Price to Book Value Related Metrics
| PE Ratio | 5.033 |
| PS Ratio | 3.739 |
| PEG Ratio | 0.0044 |
| Price to Free Cash Flow | 8.956 |
| Price | 20.66 |
| Earnings Yield | 19.87% |
| Market Cap | 1.501B |
| PEGY Ratio | 0.0044 |
| Operating PE Ratio | 10.44 |
| Normalized PE Ratio | 9.036 |